Mickelson’s PGA Standing vs. Enbrel’s DTC Spending
Phil Mickelson, 5-over, missed the cut at the Masters this year. Bummer!
Because of that, you might not see more Enbrel ads featuring Mickelson who...
The Top 20 DTC Ad Spenders in 2013 Virtually Ignored Digital
April is the nicest month -- for data about direct-to-consumer (DTC) ad spending for the previous year thanks to MM&M magazine, which published Nielsen...
An FDA Approved Opioid Delivery System
The Food and Drug Administration (FDA) announced the establishment of a docket (here) to receive suggestions, recommendations, and comments on innovative packaging, storage, and...
Tsk! Tsk! Takeda May Pay $6 Billion Penalty for Hiding Actos Cancer Link –...
According to an article in the Financial Times, "Takeda has been ordered to pay $6bn in punitive damages for hiding a possible link between...
Are FDA’s Efforts to Improve Adverse Event Reporting Being Hobbled by Pharma?
Source: FDA. 2012 data estimated based on first 6 months.
FDA resurrected a data mining project that it had abandoned for "lack of funding" but...
Pharma Is in the “Publishing” Business. Or, How I Learned to Stop Worrying and...
There seems to be a sea change in the pharma social media landscape. Instead of optimism, I'm hearing many pessimistic comments from consultants and...
Pharmaguy Celebrates TWENTY Years Publishing Pharma Info on the Web!
I just realized that this past March was the 20th anniversary of my online pharma publishing career.
In March, 1994, I began publishing oncology drug...
Is Online Pharma DTC Ad Spend Continuing Its Downward Slide?
According to Nielsen, the pharmaceutical industry's spending on Direct-to-Consumer (DTC) advertising via "measured media" increased by nearly 10% in 2013 vs. 2012 as shown...
FDA Launches Social Media Educational Initiative for Pharma
FDA NEWS RELEASE
For Immediate Release: Apr. 1, 2014
Media Inquiries: Iadora Newcomer, 301-796-1234, iadora.newcomer@fda.hhs.gov
Media Inquiries: 888-INFO-FDA
The U.S. Food and Drug Administration today announced the launch...
Pharma Finds Little to Like in Recent FDA Social Media Guidance: Delete, Limit, &...
The comments are in! As usual, the pharma industry waited until the last minute to submit comments to FDA Docket 2013-N-1430 regarding recent FDA social media draft guidance. This article provides highlights from submissions by Novartis, Shire, the Pharmaceutical Research and Manufacturers of America (PhRMA), the Biotechnology Industry Organization (BIO), Klick Health, the Social Media Compliance Council (SMCC), the Coalition for Healthcare Communication (CHC), and the Digital Health Coalition (DHC), and other interested parties.
